LATEST
Silgan / Trivium: minority stakenewBF International Best Fields Best Food / DiagramnewOpenWorld agreed to acquire Blocksight HoldingsnewMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
Agreement signedPublished 26 Jun 2024

Novo Nordisk A/S /
2seventy bio, Inc.

Novo Nordisk A/S agrees to buy 2seventy bio, Inc.

Buy side: Novo Nordisk A/S
Buy sideNovo Nordisk A/S
Target: 2seventy bio, Inc.
Target2seventy bio, Inc.
Source · 26 Jun 2024Source-verified
See the source
Buy side: Novo Nordisk A/S
Buy sideNovo Nordisk A/S
Target: 2seventy bio, Inc.
Target2seventy bio, Inc.
01 / BuyerNovo Nordisk A/S
02 / Target2seventy bio, Inc.
Source-verified
01

What happened

Novo Nordisk A/S agreed to acquire 2seventy bio, Inc., according to a filing dated June 26, 2024.

02

Who is involved, and the source

Everything on this page comes from the source below.

Advisers

Target

Advisers are not parties to the deal.

01
Source · Original source

Novo Nordisk A/S agrees to buy 2seventy bio, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.